5 Written questions
5 Multiple choice questions
- loss of HBeAg status and seroconversion to anti-HBeAg. NO CURE FOR HBV.
- Guanosine nucleoside analog. More potent than Lamivudine and adefovir. HBV use. Can elevate LFTs.
- can use immunoglobulin if known to be within 2 weeks of exposure
- Headache, nausea, vomitting, diarrhea, rash, fever, fatigue, lethargy.
- Reverse transcriptase inhibitor, chronic HBV
4 True/False questions
Combination therapy → Shown to decrease drug resistance but not to be more effective in treatment.
hepatitis a vaccine → can use immunoglobulin if known to be within 2 weeks of exposure
PEGinterferon → Polyethylene glycol preparation of interferon that slows the rate of absorption, making treatment more effective, side effects lessened, once weekly administration.
Telbivudine (Tyzeka) → Reverse transcriptase inhibitor, HBV, patients can become resistant to this treatment. Highest in safety and patient tolerance.